Phenobarbital

Phenobarbital, også kendt som phenobarbiton eller phenobarb er et medikament som anbefales af Verdenssundhedsorganisationen til behandling af visse typer epilepsi i ulande.[1] I udviklingslande bliver det ofte brugt til at behandle anfald hos små børn,[2] mens der normalt bruges andre lægemidler til at behandle større børn og voksne.[3]

Phenobarbital

Referencer

Ilangaratne, NB; Mannakkara, NN; Bell, GS; Sander, JW (1. december 2012). "Phenobarbital: missing in action". Bulletin of the World Health Organization. 90 (12): 871-871A. doi:10.2471/BLT.12.113183. PMC 3524964. PMID 23284189.
Brodie, MJ; Kwan, P (december 2012). "Current position of phenobarbital in epilepsy and its future". Epilepsia. 53 Suppl 8: 40-6. doi:10.1111/epi.12027. PMID 23205961.
"The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care NICE guidelines [CG137]". National Institute for Health and Care Excellence. januar 2012. {{cite web}}: Manglende eller tom |url= (hjælp)

Spire

Denne artikel om lægevidenskab er en spire som bør udbygges. Du er velkommen til at hjælpe Wikipedia ved at udvide den.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[Ila2012-1] Ilangaratne, NB; Mannakkara, NN; Bell, GS; Sander, JW (1. december 2012). "Phenobarbital: missing in action". Bulletin of the World Health Organization. 90 (12): 871-871A. doi:10.2471/BLT.12.113183. PMC 3524964. PMID 23284189.

[2] Brodie, MJ; Kwan, P (december 2012). "Current position of phenobarbital in epilepsy and its future". Epilepsia. 53 Suppl 8: 40-6. doi:10.1111/epi.12027. PMID 23205961.

[3] "The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care NICE guidelines [CG137]". National Institute for Health and Care Excellence. januar 2012. {{cite web}}: Manglende eller tom |url= (hjælp)